1Zur Hausen H. Papillomaviruses causing cancer: Evasion from hostcell control in early events in carcinogenesis [ J]. Natl Cancer Inst, 2000,92(9) :690 -698.
2zur Hauscn H. Papillomaviruscs and canccr: From basic study to clinical application [ J ]. Nat Rcv Canccr, 2002, 2:342 - 350.
6Di Lonardo A, Venuti A, Marcante ML. Human papillomavirus in breast cancer [ J ]. Breast Cancer Res Treat, 1992, 21 ( 2 ) : 95 - 100.
7Hennig EM, Suo Z, Thoresen S, et al. Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN Ⅲ) [ J]. Breast Cancer Res Treat, 1999,53 (2) : 121 - 135.
8Hennig EM, Kvinnsland S, Holm R, et al. Significant difference in p53and p21 protein immunoreactivity in HPV 16 positive and HPV negative breast carcinomas [ J ]. Acta Oncol, 1999, 38 (7) : 931 - 958.
9Yu Y, Morimoto T, Sasa M, et al. Human papillomavirus type 33 DNA in breast cancer in Chinese[ J]. Breast Cancer, 2000,7(1 ) : 33 -36.
10Liu Y, Klimberg VS, Andrews NR, et al. Human papillomavirus DNA is present in a subset of unselected breast cancers[ J]. J Hum Virol, 2001,4 (6) : 329 - 334.
二级参考文献15
1Neal Nathanson N. Viral Pathogenesis. Chapter 12, small DNA tumor viruses. Philadelphia:Lippincott-Raven, 1997:267～88
2Band V,Zajchowski D, Kulesa V et al. Human papillomavirus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci USA, 1990;87:463～7
3Yu Y, Morimoto T, Sasa M et al. HPV33 DNA in premalignant and malignant breast lesions in Chinese and Japanese populations. Anticancer Res, 1999;19:5057～62
4Yu Y, Morimoto T, Sasa M et al. Human papillomavirus type 33 DNA in breast cancer in Chinese. Breast Cancer, 2000;7:33～6
5Tsutsumi Y, Kawai K, Hori S et al. Ultrastructural visualization of human papillomavirus DNA in verrucous and precancerous squamous lesions. Acta Pathol Jpn, 1991;41:757～62
6Park JS, Hwang ES, Park JN et al. Physical status and expression of HPV genes in cervical cancers. Gynecol Oncol, 1997;65:121～9
7Flores ER, Lambert PF. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J Virol, 1997;71:7167～79
8Palefsky JM, Winkler B, Rabanus JP et al. Characterization of in vivo expression of the human papillomavirus type 16 E4 protein in cervical biopsy tissues. J Clin Invest, 1991;87:2132～41
9Flores ER, Allen-Hoffmann BL, Lee D et al. Establishment of the human papillomavirus type 16(HPV16) life cycle in an immortalized human foreskin keratinocyte cell line. Virology, 1999;262:344～54
10Yun K, Scherwood MJ. In situ hybridization at light and electron microscopic levels:Identification of human papillomavirus nucleic acid. Pathology, 1992;24:91～8
1Syrjanen KJ. Bronchial squamous cell carcinomas associated with epithelial changes identical to condylomatous lesions of the uterine cervix[J]. Lung, 1980, 158 (3): 131-142.
2Wang Y, Wang A, Jiang R, et al. Human papillomavirus type 16 and 18 infection is associated with lung cancer patients from the central part of China[J]. Oncol Rep, 2008, 20 (2): 333- 339.
3Zhang EY, Tang XD. Human papillomavirus type 16/18 oncoproteins: potential therapeutic targets in non-smoking associated lung cancer[J]. Asian Pae J Cancer Prey, 2012, 13 (11): 5363-5369.
4Syrj/inen KJ. Epithelial lesions suggestive of a condylomatousorigin found closely associated with invasive bronchial squamous cell carcinomas[J]. Respiration, 1980, 40 (3): 150-160.
5Bosch FX, de Sanjose S, Castellsague X. The prospects of HPV vaccination in cervical cancer prevention: results of a new independent trial[J]. Cancer Discov, 2011, 1 (5): 377-380.
6Zur HH. Papillomaviruses and cancer: from basic study to clinical application [J]. Nat Rev Cancer, 2002, 2 (5) : 342-350.
7Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years[J]. Cancer, 2005, 103 (9): 1843-1849.
8Dayyani F, Etzel C J, Liu M, et al. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)[J]. Head Neck Oncol, 2010, 2: 15.doi: 10.1186/ 1758-3284-2-15.
9Saslow D, Castle PE, Cox JT, et al. American cancer society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors[J]. CA Cancer J Clin, 2007, 57 (1): 7-28.
10Joura EA, Leodolter S, Hernandez-Avila M, et al. Efficacy of a quadrivalent prophylactic human papillomavirus (types 6, 11, 16, and 18) L1 virus-like-particle vaccine against high- grade vulval and vaginal lesions: a combined analysis of three randomised clinical trials[J]. Lancet, 2007, 369 (9574): 1693-1702.
